ABVC BioPharma Provides Vitargus® Update
30 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
Vitargus® Receives Phase II Thailand Central Research Ethics Committee Approval FREMONT, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a...
ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
16 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
01 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Enters Into $3.0 Million Clinical Services Contract with NeuCen BioMed
03 mai 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, May 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Restructures Joint Venture to Expand Access to Early-Stage Research
12 oct. 2021 08h30 HE
|
ABVC BioPharma, Inc.
Restructured Venture Also Seeks Licensing Partners for ABVC FREMONT, CA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical...
ABVC BioPharma Report Updated by Zacks/SCR
30 août 2021 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...